The FDA Is Finally Considering a New Sunscreen Ingredient. Here's What to Know
The FDA is considering the approval of a new sunscreen ingredient called bemotrizinol, which could improve the effectiveness and safety of sunscreens in the U.S. This ingredient has been used in Europe for years and is seen as a potential game-changer for American consumers. The decision on bemotrizinol is expected to be made this summer, following decades without new UV-blocking ingredients being approved in the U.S.
- ▪The FDA announced it is considering bemotrizinol, a new sunscreen ingredient.
- ▪Bemotrizinol has been used in Europe since 2000 and offers broad-spectrum protection.
- ▪Only 550 out of over 2,700 evaluated sunscreens met safety and UV protection criteria according to the Environmental Working Group.
TIME — Top files mainly under news. We currently carry 213 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | TIME — Top |
| Canonical URL | https://time.com/article/2026/05/19/new-sunscreen-ingredient-bemotrizinol-fda/ |
| Publication time | Tue, 19 May 2026 16:41:51 +0000 |
| Retrieval time | 2026-05-19T16:54:57.866Z |
| Last seen | 2026-05-19T16:54:57.866Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | qEHcmGtje5kj |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
Stop us if you’ve heard this one before: Wear sunscreen. In the U.S., this advice, so commonly bandied about, can be a bit tricky to follow. Compared to other places in the world, manufacturers in the U.S. can use only a handful of ingredients. As a result, many American sunscreens are greasy or leave a white cast on the skin. Others contain substances that may make their way into the bloodstream, according to research, though the health effects of this potential leakage aren’t clear. Finding a product you like and trust enough to wear every day—applying a full shot glass’s worth to the face and skin left exposed by a swimsuit, every two hours, if you’re following the rules—isn’t always simple.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at TIME — Top.
Discussion
0 commentsMore from TIME — Top
